Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine

The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) project designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia, identified three drug mechanisms of particular interest: dopaminergic, cholinerg...

Descripción completa

Detalles Bibliográficos
Autor principal: Koola, Maju Mathew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824953/
https://www.ncbi.nlm.nih.gov/pubmed/27069875
http://dx.doi.org/10.1016/j.scog.2016.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824953/
https://www.ncbi.nlm.nih.gov/pubmed/27069875
http://dx.doi.org/10.1016/j.scog.2016.02.001

Ejemplares similares